MTOR and central nervous system cancer: miR-199 can downregulate the expression of the mTOR signaling pathway to enhance the sensitivity of HCC to DOX.miR-199 also targets the AGAP2 gene and suppresses its expression, enhancing the sensitivity of glioma cells to temozolomide and inhibiting tumor progression.